Perceptive Advisors LLC 13D and 13G filings for BridgeBio Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 9:01 pm Purchase | 2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO | Perceptive Advisors LLC | 7,128,755 4.800% | 422,487 (+6.30%) | Filing |